Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Stock Information for Allurion Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Allurion Technologies Inc.

Veru Participates in a Virtual Investor KOL Connect Segment
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025
Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.